Connect Biopharma Holdings share price logo

Connect Biopharma Holdings

NASDAQ: CNTB

$0.93

-0.05

(-5.06%)

Live

as on

Connect Biopharma Holdings Stock Performance

as on October 3, 2026 at 4:07 am IST

  • Day's Low

    Day's High

    $0.93
    $1.08
    downward going graph

    0.01%

    Downside

    16.12%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.94
    $3.82
    downward going graph

    -1.42%

    Downside

    310.71%

    Upside

    downward going graph

Connect Biopharma Holdings share price movements today

Previous Close
$0.98
Open
$0.98
Volume
2.3M
Market Cap
$69.3M
Day's Low - High
$0.93 - $1.08
52 Week Low - High
$0.94 - $3.82

Connect Biopharma Holdings Historical Returns

1 Month Return
-64.5 %
3 Month Return
-60.17 %
1 Year Return
-29.52 %
3 Year Return
-2.03 %
5 Year Return
-95.8 %

Connect Biopharma Holdings Stock Fundamentals & Key Indicators

Check Connect Biopharma Holdings market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$69.3M

EPS (TTM)

-0.88

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-1.25

Industry PE ratio

-3.04

PEG Ratio

0.02

EBITDA

-51.8M

Revenue (TTM)

2.9M

Profit Margin

100.00%

Return On Equity TTM

-150.47%

Connect Biopharma Holdings vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Connect Biopharma Holdings with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
StrongBuy$69.3M-95.80%-1.25100.00%0.00%
StrongBuy$44.0B607.04%-23.170.00%0.00%
Neutral$76.9B-44.61%-24.13-12.57%0.00%
StrongBuy$132.5B180.98%30.1986.04%0.00%
Buy$77.3B28.74%18.1184.86%0.49%

Stock Returns calculator for Connect Biopharma Holdings Stock including INR - Dollar returns

The Connect Biopharma Holdings stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Connect Biopharma Holdings investment value today

Current value as on today

₹72,631

Returns

-₹27,369

(-27.37%)

Returns from Connect Biopharma Holdings Stock

-₹33,086 (-33.09%)

Dollar Impact

₹5,717 (+5.72%)

Analyst Recommendation on Connect Biopharma Holdings Stock

Based on 4 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 4 analysts, 100% of analysts recommend a 'BUY' rating for Connect Biopharma Holdings. Average target price of $5.88

Connect Biopharma Holdings Share Price Target

Get share price movements and forecasts by analysts on Connect Biopharma Holdings.

What analysts predicted

84.18%UPSIDE

Target Price

$5.88

Current Price

$0.9301

Analyzed by

4 Analysts

High

$10

Target

$5.88

Low

$6

Connect Biopharma Holdings target price $5.88, a slight upside of 84.18% compared to current price of $0.9301. According to 4 analysts rating.

Indian Investors' Interest in Connect Biopharma Holdings Stock

Investment in Connect Biopharma Holdings Shares on INDmoney has grown by 2400.00% in the last 30 days, indicating increased investment activity.

Time period: to

Change:2400.00% versus previous 30 day period

Search interest for Connect Biopharma Holdings Stock has increased by 1363% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:1363% versus previous 30 day period

Connect Biopharma Holdings Quarterly Profit & Loss

All numbers in Millions USD

Dec 2021
Jun 2022
Dec 2022
Jun 2023
Dec 2023
Jun 2024
Mar 2025
Jun 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
24
0
0
-
2
Gross Profit
0
-
0
0
-
24
0
0
-
2
Operating Income
-58
-59
-54
-34
-36
13
-9
-13
-15
-37
EBITDA
-55
-61
-55
-29
-35
15
-8
-12
-14
-36
Interest Expense
-
0
0
0
0
0
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-56
-59
-56
-30
-31
14
-8
-12
-15
-36
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-56
-59
-56
-30
-31
14
-8
-12
-15
-36
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
98.03%
100.00%
100.00%
0.00%
100.00%

Connect Biopharma Holdings Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Mar 2025
Mar 2026
Total Revenue
-
-
-
-
-
26
0
Gross Profit
-
-
-
-
-
26
0
Operating Income
-15
-30
-98
-119
-69
-22
-58
EBITDA
-24
-118
-201
-116
-61
-14
-54
Interest Expense
-
-
-
0
-
-
-
Depreciation
0
0
0
1
0
0
0
Income Before Tax
-24
-119
-202
-117
-61
-15
-55
Income Tax Expense
-
-
0
0
0
0
0
Net Income
-24
-119
-202
-118
-62
-15
-55
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
100.00%
100.00%

Connect Biopharma Holdings Quarterly Cash Flow

All numbers in Millions USD

Dec 2021
Jun 2022
Dec 2022
Jun 2023
Dec 2023
Jun 2024
Mar 2025
Jun 2025
Mar 2026
Jun 2026
Net Income
-56
-61
-56
-30
-31
6
-23
-12
-15
-21
Operating Cash Flow
-45
-52
-44
-31
-16
-7
-15
-12
-11
-20
Investing Cash Flow
0
-75
-6
34
40
12
-15
5
10
1
Financing Cash Flow
0
0
0
0
0
0
0
0
0
18
Change in Cash
-45
-126
-62
2
-81
28
-31
-7
0
-11

Connect Biopharma Holdings Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Mar 2025
Mar 2026
Net Income
-24
-119
-204
-116
-59
-15
-55
Operating Cash Flow
-13
-25
-85
-99
-47
-23
-51
Investing Cash Flow
0
0
-5
-83
75
-3
9
Financing Cash Flow
0
140
206
0
0
0
1
Change in Cash
-13
107
109
-168
26
-27
-39

Global Institutional Holdings in Connect Biopharma Holdings

Check out the Institutions with significant holdings in Connect Biopharma Holdings.

Funds
Holdings
Joseph Edelman
1.26%
iShares
1.06%
Vanguard
0.17%
Fidelity Concord Street Trust
0.04%
Global X
0.01%

Connect Biopharma Holdings News & Key Events

  • img

    Today's Timeline - 30 September

    Wed, 05:00 PM

    -

    Connect Biopharma reports positive Phase 2 results for rademikibart, showing significant reductions in COPD exacerbations and treatment failures.

Insights on Connect Biopharma Holdings

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 566.0% return, outperforming this stock by 595.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 82.9% return, outperforming this stock by 84.9%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, CNTB stock has moved down by -9.3%

About Connect Biopharma Holdings

Connect Biopharma Holdings Limited is a clinical-stage biopharmaceutical company dedicated to discovering and advancing immune modulators. Its primary objective is to develop treatments for serious autoimmune diseases and various inflammatory conditions. The company's lead investigational therapy is CBP-201, an anti-interleukin-4 receptor alpha antibody. This candidate is currently in Phase IIb clinical trials, targeting inflammatory allergic diseases such as atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps. Additionally, Connect Biopharma's pipeline includes CBP-307, a small molecule designed to modulate sphingosine 1-phosphate receptor 1. This receptor plays a crucial role in regulating T cell movement from lymph nodes into the bloodstream. CBP-307 is in Phase II development for treating autoimmune-related inflammatory disorders. Another preclinical-stage asset, CBP-174, is an orally administered small molecule histamine receptor 3 antagonist, being investigated for chronic pruritus (itch) associated with skin inflammation. The portfolio also features CBP-233, a humanized antibody in preclinical development that targets interleukin-33, a cytokine recognized for its involvement in T helper 2 inflammation. Established in 2012, the company maintains its headquarters in Taicang, China.
OrganisationConnect Biopharma Holdings
Headquarters3580 Carmel Mountain Road, San Diego, CA, 92130, US
IndustryBiotechnology
CEOBarry D. Quart

Key Management of Connect Biopharma Holdings

Name

Title

Dr. Barry David Quart Pharm.D.

CEO & Director

Mr. David L. Szekeres J.D.

President

Ms. Lisa Peraza CPA

Senior Vice President of Finance

Mr. Jeff Cohn J.D.

General Counsel & Corporate Secretary

Mr. Sean T. Ristine

Vice President of Human Resources

Dr. Lei Sun Ph.D.

VP of Biologics & Head of CMC

Dr. Srikanth Pendyala M.D.

Senior Vice President of Clinical Development(Consultant)

Ms. Kimberly J. Manhard

Executive VP & Chief Development Officer

FAQs

What is Connect Biopharma Holdings share price today?

Connect Biopharma Holdings share price today is $0.93 as on . Connect Biopharma Holdings share today touched a day high of $1.08 and a low of $0.93.

What is the 52 week high and 52 week low for Connect Biopharma Holdings share?

Connect Biopharma Holdings share touched a 52 week high of $3.82 on and a 52 week low of $0.94 on . Connect Biopharma Holdings stock price today i.e. is trending at $0.93,which is 75.65% down from its 52 week high and -1.40% up from its 52 week low.

What is Connect Biopharma Holdings's market capitalisation today?

Connect Biopharma Holdings market capitalisation is $0.00T as on .

How to invest in Connect Biopharma Holdings Stock (CNTB) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Connect Biopharma Holdings on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Connect Biopharma Holdings Stock (CNTB) from India?

Indian investors can start investing in Connect Biopharma Holdings (CNTB) shares with as little as ₹96.300003051758 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹963.00 in Connect Biopharma Holdings stock (as per the Rupee-Dollar exchange rate as on ). Based on Connect Biopharma Holdings share’s latest price of $0.93 as on October 2, 2026 at 10:37 pm IST, you will get 10.7515 shares of Connect Biopharma Holdings. Learn more about fractional shares .

What are the returns that Connect Biopharma Holdings has given to Indian investors in the last 5 years?

Connect Biopharma Holdings stock has given -95.8% share price returns and 28.69% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?